Table 1 Clinical demographics.

From: Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy

Patient ID

Age (years)

Sex

Cause of retinal detachment

Type of retinal detachment

Class of PVR

Preoperative visual acuity

Postoperative visual acuity

Sample analysis

PVR-02

76

Female

Traumatic, open globe injury zone 3

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand motions

Counting fingers

Fixed (S1)

PVR-03

32

Female

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand motions

20/150

Fixed and cultured (S2)

PVR-04

67

Female

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand Motions

20/125

Fixed (S3)

PVR-05

68

Male

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand motions

Hand motions

Cultured (S4)

PVR-12

64

Female

Traumatic, open globe injury zone 2

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand motions

Hand motions

1st explant

PVR-13

68

Female

Traumatic, open globe injury zone 3

Recurrent macula-off rhegmatogenous retinal detachment

C

Light perception

Hand motions

Fixed (S5)

PVR-14

64

Male

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

20/600

20/1000

Cultured (S7)

PVR-18

71

Female

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

Hand Motions

Counting Fingers

2nd explant

PVR-20

24

Female

Spontaneous

Recurrent macula-off rhegmatogenous retinal detachment

C

Light Perception

Counting Fingers

3rd explant